05-Sep-2026
Download PDF
Lincoln Pharma
Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("the SEBI Listing Regulations") we are submitting herewith the Annual Report of the Company along with the Notice of 32nd Annual General Meeting ("AGM") for the Financial Year 2025-2026.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
